ReviewMolecular brain2025
Role of autophagy in neurotoxic protein's clearance following post-ischemic stroke: where we are and what we know?
Review in Molecular brain, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The Role of PINK1/Parkin-Mediated Mitophagy in Cerebral Ischemia-Reperfusion Injury: A Review of Recent Advances.Molecular neurobiology · 2026Review
- Bridging Inflammation and Repair: The Promise of MFG-E8 in Ischemic Stroke Therapy.International journal of molecular sciences · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe role of autophagy following stroke and its underlying cascades have not yet been investigated in detail. The ischemic brain is characterized by complex pathophysiological mechanisms, including increased excitotoxicity, oxidative stress, inflammatory responses, intrinsic and extrinsic apoptotic pathways, blood-brain barrier (BBB) integrity, neurotoxic proteins, and neurodegeneration. By engaging multiple molecular pathways, autophagy plays both protective and detrimental roles in ischemic stroke. Main text: This review explores the state-of-the-art regarding autophagy’s role in neurotoxic protein clearance, neuroinflammation, oxidative stress, BBB, and neural tissue regeneration during and after ischemic stroke. Additionally, neuroinflammation is modulated by autophagy such that the inflammasomes and proinflammatory complexes that cause post-ischemic neuroinflammation are degraded. However, autophagy can be dysregulated, resulting in chronic neuro-inflammation. Moreover to counteract the excessive oxidative stress, autophagy is triggered mainly through the PINK1/Parkin pathway. In contrast, over-activated autophagy may cause neuronal damage and cell death. Autophagy maintains BBB integrity by restoring tight junction proteins. However, if dysregulated, the infiltration of inflammatory neurotoxic substances can exacerbate ischemic injury, highlighting the need for balanced regulation of autophagy. As the central nervous system (CNS) has limited regenerative capability, neural stem and progenitor cells are activated to promote neurogenesis following stroke. Autophagy can also enhance those regenerative processes. Conclusions Modulating autophagy offers potential therapeutic strategies in stroke patients by enhancing the protective effects of autophagy while minimizing its harmful consequences.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.